why choose us

First received: February 03, 2023

Clinical Trial: Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection

Study Status: Completed

Recruit Status: RECRUITING

Condition: Bone Infection

Study Type: INTERVENTIONAL


Official Title: Omadacycline Versus Standard-of-Care Oral Antibiotic Treatment for Bone and Joint Infections: An Open-Label, Non- Inferiority, Randomized, Controlled Trial

Brief Summary: The study design is a randomized, open-label, clinical trial of omadacycline vs Standard of Care (SOC) antibiotics for bone and join infection (BJI) treatment.Study participants will have their BJI regimen chosen by their treating physicians, (typically Infectious Diseases for hardware and prosthetic joint infections, or multidisciplinary Limb Salvage team for diabetic foot infections) prior to enrollment.Then participants will be randomized to an omadacycline-containing regimen versus the a priori chosen SOC…

Read more